Antifibrotic compounds and uses thereof
US9597321B2 · kind B2 · utility
2Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2015 |
| Grant date | Mar 21, 2017 |
| Priority date | — |
| Expiry date | May 5, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5377
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds having the general structural formula (I)and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving abnormal or excessive fibrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.